Know the numbers to calculate a plan…
When a patient is experiencing symptoms of preterm labour, you need to determine if her risk of preterm birth is real or perhaps quite low.¹
Quantitative fetal fibronectin testing (Rapid fFN® Test) detects concentration levels of the fFN protein to reliably indicate whether a woman is likely to give birth prematurely.²
fFN acts as an adhesive glycoprotein at the maternal-fetal interface that bonds maternal membranes to fetal membranes.
It is a biomarker for preterm delivery and is highly associated with the risk of preterm delivery when present in cervicovaginal secretions.
fFN testing is the only named biomarker test recommended by the NICE clinical guidelines for the risk assessment of preterm labour & birth. ² ³
More information and less guesswork, to better predict the likelihood of preterm birth.
References
- AW-19098-002_003 – 10Q Cassette Product Insert
- National Institute for Health and Care Excellence (NICE). Diagnostic consultation document. March 2018. Available at: https://www.nice.org.uk/guidance/gid-dg10017/documents/diagnostics-consultation-document
- National Institute for Health and Care Excellence (NICE). Preterm labour and birth guidance. Published November 2015. Available at: https://www.nice.org.uk/guidance/ng25/chapter/recommendations#diagnosing-preterm-labour-for-women-with-intact-membranes